Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meir Stampfer

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Journal of the National Cancer Institute|May 15, 2014
Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survivalYin Cao, Sara Lindström, Fredrick Schumacher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2009
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort ConsortiumRuth C Travis, Fredrick Schumacher, Joel N Hirschhorn, et al.
European Urology|January 14, 2014
Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumIrene M Shui, Sara Lindström, Adam S Kibel, et al.
Human Molecular Genetics|July 4, 2009
Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3)Jiyoung Ahn, Fredrick R Schumacher, Sonja I Berndt, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumSara Lindström, Jing Ma, David Altshuler, et al.
Plos One|March 11, 2011
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3Sara Lindstrom, Fredrick Schumacher, Afshan Siddiq, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2009
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibilityHong Lou, Meredith Yeager, Hongchuan Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)Sara Lindström, Fredrick R Schumacher, David Cox, et al.
European Urology|October 4, 2014
A genome-wide pleiotropy scan for prostate cancer riskOrestis A Panagiotou, Ruth C Travis, Daniele Campa, et al.
Carcinogenesis|December 8, 2009
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)Laure Dossus, Rudolf Kaaks, Federico Canzian, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Journal of the National Cancer Institute|May 15, 2014
Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survivalYin Cao, Sara Lindström, Fredrick Schumacher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2009
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort ConsortiumRuth C Travis, Fredrick Schumacher, Joel N Hirschhorn, et al.
European Urology|January 14, 2014
Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumIrene M Shui, Sara Lindström, Adam S Kibel, et al.
Human Molecular Genetics|July 4, 2009
Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3)Jiyoung Ahn, Fredrick R Schumacher, Sonja I Berndt, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumSara Lindström, Jing Ma, David Altshuler, et al.
Plos One|March 11, 2011
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3Sara Lindstrom, Fredrick Schumacher, Afshan Siddiq, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2009
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibilityHong Lou, Meredith Yeager, Hongchuan Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)Sara Lindström, Fredrick R Schumacher, David Cox, et al.
European Urology|October 4, 2014
A genome-wide pleiotropy scan for prostate cancer riskOrestis A Panagiotou, Ruth C Travis, Daniele Campa, et al.
Carcinogenesis|December 8, 2009
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)Laure Dossus, Rudolf Kaaks, Federico Canzian, et al.
Pageof 11